News

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP inhibitor cancer treatments, according to a study led by Weill Cornell Medicine... Read more

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During their preparation for this battle, B cells transiently revert to a more flexible, or plastic, stem-... Read more

Video of Research Matters: Personalizing Pancreatic Cancer Treatment It’s not surprising that pancreatic cancer is often referred to as a silent killer. With few early symptoms and an aggressive nature, it has one of the... Read more

A new study has discovered a molecular signal that tumors exploit to exhaust the T cells meant to destroy them—and how silencing that signal could revive the body’s immunity. The study led by Weill Cornell Medicine... Read more

Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of any gene in a cell. Such “gene-switch” tools allow scientists to “turn on” or “turn off” a target... Read more

Scientists have discovered a method to induce human endothelial cells from a small biopsy sample to multiply in the laboratory, producing more than enough cells to replace damaged blood vessels or nourish organs for... Read more

Video of Research at Risk: Rooting out treatment-resistant prostate cancer Advances in prostate cancer early detection and treatment have improved outcomes in men diagnosed with the disease . Yet doctors and scientists have... Read more

The SCOPE system can capture proteins binding to regions of DNA that control gene expression. The illustration depicts part of the process where a small guide RNA delivers a protein bearing a special amino acid to the... Read more

Skin cancer is the most common type of cancer in America. Melanoma skin cancer is the least common type, making up only 1 out of 100 skin cancers, according to the American Cancer Society . If it’s so rare, what’s the big... Read more